These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 12082609

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. p19(ARF) is dispensable for oncogenic stress-induced p53-mediated apoptosis and tumor suppression in vivo.
    Tolbert D, Lu X, Yin C, Tantama M, Van Dyke T.
    Mol Cell Biol; 2002 Jan; 22(1):370-7. PubMed ID: 11739748
    [Abstract] [Full Text] [Related]

  • 4. Induction of apoptosis in human esophageal cancer cells by sequential transfer of the wild-type p53 and E2F-1 genes: involvement of p53 accumulation via ARF-mediated MDM2 down-regulation.
    Itoshima T, Fujiwara T, Waku T, Shao J, Kataoka M, Yarbrough WG, Liu TJ, Roth JA, Tanaka N, Kodama M.
    Clin Cancer Res; 2000 Jul; 6(7):2851-9. PubMed ID: 10914734
    [Abstract] [Full Text] [Related]

  • 5. E2F-1 up-regulates c-Myc and p14(ARF) and induces apoptosis in colon cancer cells.
    Elliott MJ, Dong YB, Yang H, McMasters KM.
    Clin Cancer Res; 2001 Nov; 7(11):3590-7. PubMed ID: 11705881
    [Abstract] [Full Text] [Related]

  • 6. Human p14(ARF)-mediated cell cycle arrest strictly depends on intact p53 signaling pathways.
    Weber HO, Samuel T, Rauch P, Funk JO.
    Oncogene; 2002 May 09; 21(20):3207-12. PubMed ID: 12082636
    [Abstract] [Full Text] [Related]

  • 7. Bcl-2 is an apoptotic target suppressed by both c-Myc and E2F-1.
    Eischen CM, Packham G, Nip J, Fee BE, Hiebert SW, Zambetti GP, Cleveland JL.
    Oncogene; 2001 Oct 25; 20(48):6983-93. PubMed ID: 11704823
    [Abstract] [Full Text] [Related]

  • 8. The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2.
    Stott FJ, Bates S, James MC, McConnell BB, Starborg M, Brookes S, Palmero I, Ryan K, Hara E, Vousden KH, Peters G.
    EMBO J; 1998 Sep 01; 17(17):5001-14. PubMed ID: 9724636
    [Abstract] [Full Text] [Related]

  • 9. The mdm2 proto-oncogene sensitizes human medullary thyroid carcinoma cells to ionizing radiation.
    Dilla T, Romero J, Sanstisteban P, Velasco JA.
    Oncogene; 2002 Apr 04; 21(15):2376-86. PubMed ID: 11948421
    [Abstract] [Full Text] [Related]

  • 10. Human ARF binds E2F1 and inhibits its transcriptional activity.
    Eymin B, Karayan L, Séité P, Brambilla C, Brambilla E, Larsen CJ, Gazzéri S.
    Oncogene; 2001 Mar 01; 20(9):1033-41. PubMed ID: 11314038
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Activation of ARF by oncogenic stress in mouse fibroblasts is independent of E2F1 and E2F2.
    Palmero I, Murga M, Zubiaga A, Serrano M.
    Oncogene; 2002 May 02; 21(19):2939-47. PubMed ID: 12082524
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Arf induces p53-dependent and -independent antiproliferative genes.
    Kuo ML, Duncavage EJ, Mathew R, den Besten W, Pei D, Naeve D, Yamamoto T, Cheng C, Sherr CJ, Roussel MF.
    Cancer Res; 2003 Mar 01; 63(5):1046-53. PubMed ID: 12615721
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.